Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchGenethon Announces Latest Advances in Gene Therapies for Various Diseases at ESGCT 31st Annual Congress in Rome, Italy.
Oct 21, 2024
RomeBiotechnologyHealth CareGeneticsTherapeutics
Product Description
Genethon will showcase its pioneering research and innovations in gene therapy at the European Society of Gene & Cell Therapy’s 31st Annual Congress from October 22 to 25, 2024, featuring 20 scientists presenting significant developments that promise to change patients' lives.
Company Information
Company
Genethon
Location
Rome, Lazio, Italy
About
Généthon is a pioneer in the discovery and development of gene therapies for rare diseases, established by the AFM-Téléthon. The organization employs over 200 scientists and professionals dedicated to developing innovative therapies that improve the lives of patients with rare genetic diseases. It is known for its contributions to the field, including the first gene therapy for spinal muscular atrophy. Currently, Genethon has multiple products in clinical trials targeting various conditions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genethon ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.